Ascendis Pharma A/S (Ascendis Pharma A/S) Common Stock : $8.5 Mil (As of Dec. 2023)

View and export this data going back to 2015. Start your Free Trial

What is Ascendis Pharma A/S Common Stock?

Ascendis Pharma A/S's quarterly common stock declined from Jun. 2023 ($8.3 Mil) to Sep. 2023 ($8.3 Mil) but then increased from Sep. 2023 ($8.3 Mil) to Dec. 2023 ($8.5 Mil).

Ascendis Pharma A/S's annual common stock declined from Dec. 2021 ($8.6 Mil) to Dec. 2022 ($8.1 Mil) but then increased from Dec. 2022 ($8.1 Mil) to Dec. 2023 ($8.5 Mil).

Ascendis Pharma A/S Common Stock Historical Data

The historical data trend for Ascendis Pharma A/S's Common Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ascendis Pharma A/S Common Stock Chart

Ascendis Pharma A/S Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Common Stock

Get a 7-Day Free Trial

7.16

8.78

8.64

8.13

8.45

Ascendis Pharma A/S Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Common Stock	Get a 7-Day Free Trial															8.13	8.24	8.34	8.26	8.45

Ascendis Pharma A/S Common Stock Calculation

Common stock is listed on the Balance Sheet at the par value of the total shares outstanding of a company.

The par value of common stocks is meaningless. It is usually set at an absurdly low number.

Ascendis Pharma A/S (Ascendis Pharma A/S) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Ascendis Pharma A/S (NAS:ASND) » Definitions » Common Stock

Comparable Companies

Traded in Other Exchanges

ASND:Mexico A71:Germany A1SN34:Brazil

Address

Tuborg Boulevard 12, Hellerup, DNK, DK-2900

Website

http://www.ascendispharma.com

Ascendis Pharma A/S is a biopharmaceutical company. It develops prodrug therapies with profiles to address large markets with unmet medical needs with its Transcon technology. The firm's product pipeline includes Transcon growth hormone, Transconpeptides, Transcon PTH, Transcon CNP, and others. It operates in North America, China, and Europe and derives the majority of its revenue from North America.